Correlation Between Neuropace and Biotricity

Can any of the company-specific risk be diversified away by investing in both Neuropace and Biotricity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Biotricity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and Biotricity, you can compare the effects of market volatilities on Neuropace and Biotricity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Biotricity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Biotricity.

Diversification Opportunities for Neuropace and Biotricity

0.02

Correlation Coefficient

Neuropace  Biotricity

Significant diversification

The 3 months correlation between Neuropace and Biotricity is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Biotricity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotricity and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Biotricity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotricity has no effect on the direction of Neuropace i.e., Neuropace and Biotricity go up and down completely randomly.

Pair Corralation between Neuropace and Biotricity

Given the investment horizon of 90 days Neuropace is expected to generate 0.91 times more return on investment than Biotricity. However, Neuropace is 1.1 times less risky than Biotricity. It trades about 0.04 of its potential returns per unit of risk. Biotricity is currently generating about -0.02 per unit of risk. If you would invest  543.00  in Neuropace on February 26, 2024 and sell it today you would earn a total of  217.00  from holding Neuropace or generate 39.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  Biotricity

Neuropace

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neuropace has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in June 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Biotricity

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Biotricity are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Biotricity showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neuropace and Biotricity

The main advantage of trading using opposite Neuropace and Biotricity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Biotricity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will offset losses from the drop in Biotricity's long position.

The idea behind Neuropace and Biotricity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.